merckaccessprogram-zinplava.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Merck Access Program for ZINPLAVA™ |
| Description | THE MERCK ACCESS Eligible patients prescribed ZINPLAVA™ (bezlotoxumab) can learn more about product access from |
| Keywords | access to zinplava |
Server Information
| WebSite | |
| Host IP | 13.248.192.141 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
merckaccessprogram-zinplava.com Valuation
|
US$3,131,677
Last updated: 2023-05-13 13:27:45
merckaccessprogram-zinplava.com has Semrush global rank of 3,379,756. merckaccessprogram-zinplava.com has an estimated worth of US$ 3,131,677, based on its estimated Ads revenue. merckaccessprogram-zinplava.com receives approximately 361,348 unique visitors each day. Its web server is located in United States, with IP address 13.248.192.141. According to SiteAdvisor, merckaccessprogram-zinplava.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,131,677 |
| Daily Ads Revenue | US$2,891 |
| Monthly Ads Revenue | US$86,724 |
| Yearly Ads Revenue | US$1,040,681 |
| Daily Unique Visitors | 24,090 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| merckaccessprogram-zinplava.com. 300 IN | A | IP: 13.248.192.141 | |
| merckaccessprogram-zinplava.com. 300 IN | A | IP: 76.223.73.75 | |
| merckaccessprogram-zinplava.com. 86400 IN NS | NS | NS Record: ns-117.awsdns-14.com. | |
| merckaccessprogram-zinplava.com. 86400 IN NS | NS | NS Record: ns-1281.awsdns-32.org. | |
| merckaccessprogram-zinplava.com. 86400 IN NS | NS | NS Record: ns-1885.awsdns-43.co.uk. | |
| merckaccessprogram-zinplava.com. 86400 IN NS | NS | NS Record: ns-564.awsdns-06.net. | |
| merckaccessprogram-zinplava.com. 300 IN | TXT | TXT Record: v=spf1 -all | |
| merckaccessprogram-zinplava.com. 300 IN | TXT | TXT Record: google-site-verification=g5f3A4BMnxpZQs6h4l6bTGwZMz-tS-oQF0ANQn8YK3Q | |
| merckaccessprogram-zinplava.com. 300 IN | TXT | TXT Record: m83z3cyhftsty8vmv5vq3f944lwbs652 |
HtmlToTextCheckTime:2023-05-13 13:27:45
| Health Care Professionals | Patients and Caregivers Physician Prescribing Information | Patient Product Information ENROLL NOW The Merck Access Program Coding & Billing Coverage & Reimbursement Information Financial Assistance Co-pay Assistance Options for Eligible Patients The Merck Patient Assistance Program Product Distribution Forms & Documents YES NO The Merck Co-pay Assistance Program for ZINPLAVA™ (bezlotoxumab) Injection 25 mg/mL ("Program Product") To receive benefits under the Co-pay Assistance Program, the patient must enroll in the Co-pay Assistance Program and be accepted as eligible. Patient may contact The Merck Access Program for current Program Product(s) subject to these Terms and Conditions. Patient must be prescribed the Program Product for an FDA-approved indication. Patient must be 18 years of age or older and must have private health insurance that provides coverage for the cost of the Program Product under a medical benefit plan. The Co-pay Assistance Program |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: awselb/2.0 Date: Tue, 21 Dec 2021 12:05:19 GMT Content-Type: text/html Content-Length: 134 Connection: keep-alive Location: https://www.merckaccessprogram-zinplava.com:443/ HTTP/2 200 content-type: text/html;charset=UTF-8 date: Tue, 21 Dec 2021 12:05:19 GMT set-cookie: AWSALB=yyIIInOMcdGsLiO/rTTwSNRzzXKF85M4244V8tPSo21rPVM5TQgCqgOQKqw206HMXAY/yaV6ksjxzvItiT3cYpoiniPVr0+Ln3C6qSXJh64r5xJnCanVrSqQVOXD; Expires=Tue, 28 Dec 2021 12:05:19 GMT; Path=/ set-cookie: AWSALBCORS=yyIIInOMcdGsLiO/rTTwSNRzzXKF85M4244V8tPSo21rPVM5TQgCqgOQKqw206HMXAY/yaV6ksjxzvItiT3cYpoiniPVr0+Ln3C6qSXJh64r5xJnCanVrSqQVOXD; Expires=Tue, 28 Dec 2021 12:05:19 GMT; Path=/; SameSite=None; Secure server: Apache vary: Referer,X-Alt-Referer,Accept-Encoding cache-control: private, no-store, no-cache, must-revalidate pragma: no-cache expires: Thu, 01 Jan 1970 00:00:00 GMT set-cookie: JSESSIONID=73917ACC9D1A14C77C48D64FB619D902; Path=/; Secure; HttpOnly set-cookie: svcacess=8212701da90219a625b0428ee51472fc; Path=/; Secure x-xss-protection: 1; mode=block x-content-type-options: nosniff set-cookie: oam.Flash.RENDERMAP.TOKEN=1k64wrw7; Path=/foundation access-control-request-headers: Authorization, Content-Type content-security-policy: frame-ancestors 'self' https://*.facebook.com; strict-transport-security: max-age=31536000 x-cache: Miss from cloudfront via: 1.1 e6fc68fd040718147cda2e3ef6f63637.cloudfront.net (CloudFront) x-amz-cf-pop: EWR50-C1 x-amz-cf-id: NOWphl9l1dPomNXG5jYKxxXeyBcuKsIK7JPgBKk4ZbQlxu8pOFk8bw== |
merckaccessprogram-zinplava.com Whois Information
Domain Name: MERCKACCESSPROGRAM-ZINPLAVA.COM Registry Domain ID: 2021269929_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-03-12T10:09:38Z Creation Date: 2016-04-13T13:22:23Z Registry Expiry Date: 2023-04-13T13:22:23Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-117.AWSDNS-14.COM Name Server: NS-1281.AWSDNS-32.ORG Name Server: NS-1885.AWSDNS-43.CO.UK Name Server: NS-564.AWSDNS-06.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T08:36:34Z <<< |